01OverviewDefinition, clinical context and the essential points that orientate the chapter.
Visual aura is a transient neurological phenomenon associated with migraine. A typical episode evolves over minutes, often beginning as a small shimmering or zigzag area that expands across part of the visual field and then clears. Positive phenomena and a negative scotoma can coexist. Headache may follow, overlap or be absent, so the diagnosis depends on the visual time course and accompanying features rather than the presence of pain alone.
The term ocular migraine is ambiguous and should not substitute for a careful description. Cortical visual aura, transient monocular ischaemia, retinal traction and other disorders can all be reported as flashing or blurred vision. The history should establish onset, progression, duration, completeness of recovery and whether the phenomenon was monocular or present in the same part of space through either eye. First, changed or atypical episodes deserve reassessment even in someone who already has migraine.
Key points
- Typical aura is fully reversible, develops gradually over at least five minutes and lasts five to sixty minutes.
- Visual aura may include spreading zigzags, shimmering edges, spots or a missing area, and can occur without headache.
- A cortical aura affects visual space represented in both eyes, although the patient may initially describe it as one-eye trouble.
- Ask what remains visible when either eye is covered; a strictly monocular negative curtain requires assessment for retinal and vascular causes.
- Established typical migraine with a normal assessment does not require brain imaging solely for reassurance.
- Acute migraine treatment addresses the headache and associated symptoms; a response to medication cannot establish the cause of an unexplained visual event.
- Sumatriptan tablet dosing and contraindications are product-specific, and previous stroke or TIA excludes its use in the cited UK product.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
Migraine susceptibility
Migraine is a neurological disorder in which susceptibility and triggers vary between individuals. Visual aura can occur with or without the headache phase, and the same person may experience attacks with different combinations of symptoms.
Vascular and ocular mimics
Retinal ischaemia, cerebral ischaemia and retinal traction can produce transient or persistent visual disturbance. These disorders require separate assessment because their mechanisms, urgency and treatment differ from a typical migraine aura.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Transient cortical disturbance
The gradual progression of a typical visual aura is associated with a spreading change in cortical activity. This helps explain an evolving visual-field phenomenon rather than a fixed lesion confined to one eye.
- 2Positive and negative phenomena
Altered cortical processing can generate shimmering or geometric visual experiences alongside a missing area of vision. The combination and progression are more informative than treating all flashes or all scotomata as one diagnosis.
- 3Visual-field representation
The visual cortex represents the opposite side of space using input from both eyes. A cortical aura can therefore feel more prominent on one side while remaining visible when either eye is tested separately.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Ask the patient to reconstruct the episode in order, including how quickly it reached its maximum extent. NICE describes typical aura as fully reversible, developing gradually over at least five minutes and lasting five to sixty minutes. An ongoing deficit should not be treated as an ordinary resolved aura.
Shimmering lines, scintillating edges or a spreading geometric shape support an aura pattern, but positive symptoms are not exclusive to migraine. Determine whether a missing area followed or accompanied the pattern and whether normal vision returned completely.
Ask whether the patient covered either eye during the event, or have them draw the affected field for each eye. A cortical event may be more noticeable on one side but remains represented in both eyes. Strictly monocular symptoms are atypical and need a different diagnostic assessment.
Typical aura can include reversible sensory or speech symptoms, but motor weakness, diplopia, poor balance and reduced consciousness require consideration of other diagnoses and referral. Sudden maximal headache, fever or a new persistent focal deficit changes the urgency.
An abrupt dark curtain or blackout suggests a different time course from a spreading visual aura. New flashes with floaters or a peripheral shadow can reflect retinal traction or detachment. In an older adult with visual loss, ask about jaw claudication, scalp tenderness and new headache.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Structured history and bedside examinationFirst step - Why
- Determine whether the event fits a typical reversible aura or needs urgent alternative assessment.
- Interpretation and limitations
- Document true monocularity, onset speed, duration, progression and recovery, with acuity, pupils, fields and relevant neurological findings. A normal examination between episodes does not exclude a TIA or prove that an unusual event was migraine.
- 02
Emergency stroke or retinal assessment when indicated - Why
- Identify time-sensitive ischaemic or structural causes of acute visual disturbance.
- Interpretation and limitations
- Persistent sudden field loss follows an emergency pathway. A resolved suspected TIA requires immediate referral for specialist assessment within twenty-four hours. New flashes, floaters and a shadow need urgent retinal assessment, rather than classification by the word flashing alone.
- 03
Selective neuroimaging and specialist review - Why
- Investigate atypical aura features or a changed clinical pattern.
- Interpretation and limitations
- NICE advises further investigation or referral for symptoms such as monocular visual disturbance, diplopia, motor weakness, poor balance or reduced consciousness. Imaging is not routinely indicated solely to reassure someone with an established typical migraine diagnosis and no concerning findings.
- 04
Headache and visual-event diary - Why
- Clarify recurrent typical episodes and measure treatment response once urgent causes have been assessed.
- Interpretation and limitations
- Record timing, duration, visual pattern, headache features, medication days and possible triggers. A diary can support a coherent diagnosis and identify frequent acute-medication use, but it must not become a reason to defer assessment of an unresolved red flag.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Retinal or cerebral TIA
An abrupt negative blackout or field defect, particularly in a vascular-risk context, may represent ischaemia even if it resolves. A normal interval examination does not remove the need for urgent specialist assessment.
Retinal tear or detachment
New flashes and floaters can arise from traction on the retina, with a curtain or shadow suggesting detachment. A dilated retinal examination is needed when this pattern is suspected, rather than reassurance based on migraine history.
Occipital or other neurological disease
Seizures, structural lesions and other neurological disorders can cause unusual recurrent visual experiences. Brief stereotyped events, persistent abnormalities or additional neurological findings warrant assessment beyond the typical migraine pathway.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01EmergencyPersistent or vascular-pattern visual symptomsFirst stepThe event is abrupt, persistent, strictly monocular with ischaemic features or accompanied by acute neurological red flags.+
- 1Arrange immediate emergency assessment for ongoing visual loss, stroke features or thunderclap headache and record symptom timing.
- 2If a resolved event is suspected to be a TIA, use the urgent TIA pathway rather than waiting for another episode.
- 3Seek urgent ophthalmic assessment for a retinal curtain, new flashes with floaters or a suspected arteritic visual event.
- 4Avoid using a triptan response as a diagnostic test while a serious neurological or retinal cause remains possible.
02DiagnosisRecurrent typical reversible auraThe history and examination support a stereotyped gradual aura with complete recovery and no red flags.+
- 1Explain the diagnosis using the patient's sequence of visual symptoms, including the possibility of aura without headache.
- 2Offer a diary to assess frequency, impact and medication use, and discuss regular sleep, meals and manageable triggers.
- 3Explain which changes require reassessment, including persistent loss, a new monocular curtain, weakness or a substantially changed pattern.
- 4Avoid brain imaging solely for reassurance when the established diagnosis and clinical assessment do not indicate it.
03ManagementTreat associated migraine headacheAn established migraine attack causes headache or other troublesome symptoms after appropriate diagnostic assessment.+
- 1Discuss NICE acute options such as an oral triptan with an NSAID or paracetamol, or a suitable single agent according to preference and comorbidity.
- 2Choose a medicine and formulation with an appropriate licensed or explicitly specialist-directed regimen and review vascular, hepatic and interaction risks.
- 3Review frequent or disabling attacks for preventive treatment rather than repeatedly increasing acute medication use.
- 4Arrange specialist advice for complex presentations, pregnancy-related treatment decisions or persistent disability despite an adequate management plan.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
Sumatriptan tablets for established migraine headache
For adults covered by the cited tablet SmPC, take 50 mg orally at headache onset; some require 100 mg. If there was an initial response followed by recurrence, a further dose may be taken after at least two hours, with a maximum of 300 mg in twenty-four hours. Do not repeat for the same attack if the first dose did not work. In mild-to-moderate hepatic insufficiency, consider a lower 25–50 mg dose.The cited product is not recommended below eighteen or above sixty-five years. Contraindications include previous stroke or TIA, ischaemic or vasospastic coronary disease, peripheral vascular disease, severe hepatic impairment, moderate or severe hypertension, and mild uncontrolled hypertension. Avoid concomitant ergot or other triptan treatment and MAO inhibitors, including within two weeks of their withdrawal. Check required separation intervals, serotonergic interactions and pregnancy or breastfeeding circumstances before prescribing.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Missed time-sensitive disease
Misclassifying a retinal or cerebral ischaemic event as aura can delay treatment and prevention of further injury. The main protective step is accurate attention to onset, localisation, recovery and changes from the established pattern.
Migraine-related disability
Frequent visual episodes and associated headache can interrupt reading, work and safe activity. A treatment plan should address the functional burden while recognising that many isolated brief auras do not require acute medication.
Medication-overuse headache
Frequent use of acute headache medicines can contribute to persistent or worsening headache. Monitoring treatment days and considering preventive management are more useful than allowing repeated escalation of acute medication alone.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- Track the frequency and duration of aura, completeness of visual recovery and whether any episode differs from the established pattern.
- Record acute treatment days as well as dose; headache developing or worsening with triptans on ten or more days monthly for at least three months raises concern for medication-overuse headache.
- Review treatment benefit, adverse effects, cardiovascular history and new medicines before renewing an ineffective or unsuitable acute regimen.
- Discuss functional impact and preventive options when attacks interfere with work, safety or daily life, while reassessing any new focal or monocular symptom.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
Aura without headache still needs pattern recognition
Absence of headache does not rule out aura, particularly in an established recurrent pattern. A first late-onset negative visual event, however, should not be assigned that diagnosis merely because painless aura is possible.
Retinal migraine is a diagnosis of exclusion
A label of retinal migraine should be reserved for appropriately investigated strictly monocular episodes after alternative causes have been assessed. Ordinary cortical visual aura is more often responsible for bilateral visual-field phenomena that patients describe imprecisely.
Hormonal contraception warrants review
NICE advises against routinely offering combined hormonal contraception to people with migraine with aura. Confirm the aura history and arrange an appropriate contraceptive review rather than leaving a newly recognised pattern unaddressed.
Medication cannot validate an uncertain diagnosis
A headache may improve after an analgesic or triptan regardless of the cause of a preceding visual disturbance. Diagnostic confidence must come from the clinical assessment, not from retrospective interpretation of symptom relief.
Product-specific reproductive advice
Use in pregnancy requires an individual benefit-risk assessment. The cited sumatriptan SmPC says infant exposure can be minimised by avoiding breastfeeding for twelve hours after a dose and discarding milk expressed during that period; discuss the practical plan rather than leaving an unexplained interruption.
11Common pitfallsFrequent interpretation and management errors.
- 01
Using ocular migraine as a catch-all label without determining whether the symptom was monocular or homonymous.
- 02
Assuming that positive flashing symptoms automatically exclude retinal disease or cerebral ischaemia.
- 03
Giving a triptan for an unexplained focal event in a patient whose vascular history or presentation makes it unsuitable.
- 04
Requesting reassurance imaging for every established typical aura while delaying urgent assessment of a genuinely changed pattern.